Chargement en cours...
Comparisons of weight changes between sodium‐glucose cotransporter 2 inhibitors treatment and glucagon‐like peptide‐1 analogs treatment in type 2 diabetes patients: A meta‐analysis
AIMS/INTRODUCTION: To evaluate the efficacy of weight changes from baseline of the sodium‐glucose cotransporter 2 (SGLT2) inhibitors treatment and glucagon‐like peptide‐1 (GLP‐1) analogs treatment after comparisons with a placebo in type 2 diabetes patients, and the associated factors. MATERIALS AND...
Enregistré dans:
| Publié dans: | J Diabetes Investig |
|---|---|
| Auteurs principaux: | , , , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
John Wiley and Sons Inc.
2017
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5497054/ https://ncbi.nlm.nih.gov/pubmed/28106956 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jdi.12625 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|